INC Research CEO Jamie Macdonald is stepping down in October and will be replaced by current president and COO Allstair Macdonald.

Macdonald will step down from the board at that time and will continue as Vice Chairman to assist in the transition of his CEO responsibilities until Feb. 28, 2017.

Macdonald said in a statement, “This year marks my 5th year anniversary with INC Research and it has been an exciting, rewarding and successful time. I committed to myself that I would re-evaluate my priorities at this time and am fortunate that INC has in place a strong internal leadership team and successor to allow me to do that.  I am proud to have led the Company through a significant period of growth and look forward to assisting Alistair and the board with the transition as vice chair.”

Prior to assuming his current role as COO, Macdonald was president, Clinical Development Services for INC Research. He has more than 20 years’ of experience in the pharmaceutical industry and is based at the Company’s European Headquarters in Camberley, United Kingdom.

INC Research (Nasdaq: INCR) is a global contract research organization (“CRO”) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.